The Risk of Colon Cancer in Inflammatory Bowel Disease | OMICS International | Abstract
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

The Risk of Colon Cancer in Inflammatory Bowel Disease

Ross Jones, Martin Scobey and Jianfeng Cheng*

Division of Gastroenterology, Internal Medicine, UNC School of Medicine Charlotte, Carolinas Medical Center, USA

*Corresponding Author:
Jianfeng Cheng
Clinical Assistant Professor of Medicine
UNC School of Medicine Charlotte campus
Division of Gastroenterology
Department of Internal Medicine
Carolinas Medical Center, Charlotte, NC 28203, USA
Tel: 704 355-7470
Fax: 704 355-0770
E-mail: [email protected]

Received date: December 12, 2013; Accepted date: December 30, 2013; Published date: January 08, 2014

Citation: Jones R, Scobey M, Cheng J (2014) The Risk of Colon Cancer in Inflammatory Bowel Disease. J Gastroint Dig Syst 4:164. doi:10.4172/2161-069X.1000164

Copyright: © 2014 Jones R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Inflammatory Bowel Disease (IBD) involves chronic inflammation in the patient’s digestive track, leading to the development of ulcerative colitis and Crohn’s disease. IBD is painful and debilitating disease that develops into life threatening risk in the long run, particularly colorectal carcinoma (CRC). As per the studies, there are 18% of chances for the IBD to develop into colorectal carcinoma after 30 years. Although IBD is contributing to only 1% of overall Colorectal Cancer cases, the mortality rate is pretty high among the colorectal cancer developed due to IBD. The present article prescribes guidelines for screening and surveillance that minimizes the risks of CRC.